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ABSTRACT
Objective: The objective of this study was to identify
determinants for tuberculosis (TB) among HIV-infected
adults in Northwest Ethiopia.
Design: Case–control study.
Setting: Three hospitals and 10 health centres in
Northwest Ethiopia.
Participants: A total of 446 individuals consented to
participate in the study (150 cases and 296 controls).
Cases were HIV-infected adults diagnosed with active TB,
and controls were HIV-infected adults without active TB.
Main outcome measure: The link between TB and
determinants was assessed using logistic regression.
Determinants were categorised as sociodemographic,
host-related, clinical and environmental.
Results: Smoking (adjusted OR (AOR) 5.47; 95% CI
2.26 to 13.22), presence of a TB patient in the family
(AOR 2.66; 95% CI 1.25 to 5.66), alcohol consumption
(AOR 2.49; 95% CI 1.29 to 4.80) and chewing khat (AOR
2.22; 95% CI 1.11 to 4.41) were independent
determinants for increased occurrence of TB. Highly
active antiretroviral therapy (HAART) (AOR 0.25; 95% CI
0.13 to 0.51), isoniazid preventive therapy (IPT) (AOR
0.22; 95% CI 0.11 to 0.41) and cotrimoxazole preventive
therapy (AOR 0.32; 95% CI 0.19 to 0.55) had a protective
effect against TB.
Conclusions: HIV-infected adults with substance abuse
(tobacco smoking, khat chewing and alcohol) should be
prioritised for TB screening. This study reaffirmed that
HAART and IPT are some of the best strategies for
reducing TB occurrence in HIV-infected adults. These
findings provide impetus to intensify tracing of TB
household contacts.
INTRODUCTION
The advent of HIV was a massive setback for
the prevention and control of tuberculosis
(TB).1 TB is the leading cause of morbidity
and mortality among people with HIV.2
There is a strong synergy between TB and
HIV infection in HIV high-burden countries
particularly in resource-limited settings
where the impacts of both diseases are more
signiﬁcant.3
One-third of the world’s population is
infected with TB.2 In 2013, an estimated 9.0
million people developed TB; 1.1 million
were HIV infected.4 Ethiopia ranks as the
seventh most TB burdened country in the
world.5
In resource-limited settings, the healthcare
systems are overwhelmed by the preventive,
therapeutic and diagnostic challenges of the
‘HIV–TB syndemic’. In Ethiopia, the dual
epidemics have drained resources and over-
burdened the already very limited health
work-force.1 HIV increases life time risk of
developing TB.6 However, HIV is not the
only determinant for developing TB; various
others contribute to TB–HIV co-infection.
Previous studies have identiﬁed sociodemo-
graphic,7 8 clinical,9 10 life style11 12 and
environmental13 determinants for TB.
However, among HIV-infected adults, the
determinants for TB are still not well
described, particularly in a resource-limited
setting. Determinants for TB among
HIV-positive adults vary from one setting to
another. Therefore, a context-speciﬁc study
in a high-burdened TB/HIV region is indi-
cated. This study aims to assess the
Strengths and limitations of this study
▪ This is the first multicentre case–control study in
Northwest Ethiopia to investigate determinants
for tuberculosis (TB) in HIV-infected adults.
▪ The study identified determinants for TB that will
be important for prioritising TB screening, treat-
ment, prevention and control.
▪ This study reaffirmed that highly active antiretro-
viral therapy and isoniazid therapy are some of
the best strategies for reducing TB among
HIV-infected adults in resource-limited settings.
▪ As we used a retrospective case–control
approach, no temporal relationship could be
established and the study design did not allow
proof of causation.
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determinants for TB among HIV-infected adults in
Northwest Ethiopia.
METHODS
Study design
We conducted a multicentre case–control study from 12
May to 5 June 2014 in Northwest Ethiopia. All govern-
mental health institutions in 10 districts were included
(ie, Bahir Dar, Dangella, Kossober, Fnote Selam, Bure,
Dur Betie, Deber Tabor, Wereta, Addis Zemen and
Nefas Mewcha).
Participants
Cases were HIV-infected adults diagnosed with active TB
and on TB treatment during the data collection period.
The diagnosis of active TB was based on one or more
TB diagnostic investigations (sputum microscopy, X-ray,
histopathology, culture or molecular). Controls were
HIV-infected adults without TB. All controls were
actively screened for TB to rule out TB. The screening
procedure included history taking for four symptoms at
each visit (cough, weight loss, night sweating and fever).
If the patient presented with any one of these symptoms,
this patient was a suspected TB case and was investigated
according to the national guidelines for TB–HIV.1 In
hospitals, sputum microscopy, histopathology and radi-
ology examinations are used as the TB diagnostic tools.
In health centres, sputum microscopy is the main-stay
TB diagnostic tool, and patients are sent for other diag-
nostic evaluation to hospitals and private institutions
where the diagnostic tools are available.
Sample size calculation
The sample size was calculated using Epi Info V.7 soft-
ware. The study was designed to have 80% statistical
power with a level of signiﬁcance at 5% and a case to
control ratio of 1:2. Assuming the proportion of low
CD4 cell count was 5.9% for the controls and 13.9% for
the cases,13 the calculated sample size was 144 for cases
and 287 for controls using the two-proportions formula.
Allowing for a non-response rate of 10%, the resulting
sample size was 474 (158 cases and 316 controls). The
sample size was calculated for exposure status of differ-
ent variables: cotrimoxazole preventive therapy (CPT),
isoniazid preventive therapy (IPT) and CD4. We took
the largest sample among these exposure variables.
Sampling procedures
A total of 52 health institutions provide HIV care ser-
vices in 44 districts of Awie, West Gojjam and South
Gondar Zones.14 Ten districts were randomly selected,
and all health institutions in the 10 districts were
included in the study. Three hospitals and 10 health
centres were included. HIV-infected adults diagnosed
with conﬁrmed active TB were recruited as cases, while
those without active TB were recruited as controls. Study
subjects who were unable to give informed consent and
subjects with suspected but unconﬁrmed TB were
excluded. All TB–HIV co-infected patients attending
HIV care clinics and those who were receiving TB treat-
ment were included. Controls were allotted on the basis
of the number of cases available in each facility, with a
control to case ratio of 2:1, and sampled by systematic
random sampling with a sampling interval of ﬁve.
Data collection and analysis
Data were collected from two sources. Trained nurses
who were in charge of an HIV care clinic conducted
face to face interviews with study participants by using
structured questionnaires that were prepared in English,
translated into Amharic and back translated, and pre-
tested for consistency and ease of understanding. The
primary data were collected to assess sociodemographic
variables (age, sex, educational and marital status) and
host-related variables (cigarette smoking, khat chewing
and alcohol consumption). A person with substance
abuse (chewing khat, alcohol consumption or smoking)
was deﬁned as an individual who is currently using the
substance or has a history of regular substance abuse.
Environmental determinants included the presence of
ﬂooring, latrine and separate kitchen in the house.
Trained nurses also collected data from patient’s’
records to assess clinical variables: highly active
Table 1 Sociodemographic and host-related
determinants of HIV-infected adults in Northwest Ethiopia,
2014
Variable Cases Controls Total
Sex
Male 69 (46) 108 (36.5) 177 (39.7)
Female 81 (54) 188 (63.5) 269 (60.3)
Education
No formal
education
46 (30.7) 120 (40.5) 166 (37.2)
Primary 48 (32) 78 (26.4) 126 (28.3)
Secondary 42 (28) 60 (20.2) 102 (22.9)
Tertiary 14 (9.3) 38 (12.8) 52 (11.6)
Marital status
Married 53 (35.3) 141 (47.6) 194 (43.5)
Divorce/widowed 50 (33.3) 98 (33.1) 148 (33.2)
Never married 47 (31.3) 57 (19.3) 104 (23.3)
Smoking
Yes 25 (16.7) 12 (4) 37 (8.3)
No 125 (83.3) 284 (96) 409 (91.7)
Khat chewing
Yes 44 (29.3) 37 (12.5) 81 (18)
No 106 (70.7) 259 (87.5) 365 (82)
Alcohol
Yes 49 (32.7) 49 (16.6) 98 (22)
No 101 (67.3) 247 (83.4) 348 (78)
Previous history of TB
Yes 41 (27.3) 50 (16.9) 91 (20.4)
No 109 (72.7) 246 (83.1) 355 (79.6)
Values are n (%).
TB, tuberculosis.
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antiretroviral therapy (HAART), CD4 cell count, CPT
and IPT. Data collection procedures were supervised by
medical ofﬁcers.
Data were entered into Epi-info V.7 and analysis was
performed with SPSS V.20. Frequencies and proportions
were used to describe the study subjects in relation to
the studied variables. OR (95% CI) and p value were
used to measure strength of association and identify stat-
istically signiﬁcant results. Logistic regression models
were applied to assess the relationship between determi-
nants and TB. Confounding variables were identiﬁed by
applying logistic regression models. Multivariable ana-
lysis (backward stepwise) was used. The Hosmer–
Lemeshow test was applied and the ﬁt of the model was
checked: a poor ﬁt of the model if the p value is <0.05
and good ﬁt if the p value is >0.05. In this study the
model adequately ﬁtted the data and the p value was
0.34.
Ethics considerations
Ethical approval from the Heidelberg Ethics
Commission was obtained. In addition, ethical approval
from the country in which the research was conducted—
Amhara Regional Research and Ethical Core Process,
Bahir Dar, Ethiopia—was granted. Written permission to
conduct the study was obtained from each health institu-
tion involved in the study. Since there were illiterate
participants, the data collectors informed each study par-
ticipant about the informed consent sheet. Informed
oral consent was obtained from each study participant.
The data collectors documented the participant’s
consent on the informed consent sheet. This consent
procedure was approved by the ethics commission.
RESULTS
Sociodemographic and host-related determinants of
HIV-infected adults
A total of 446 subjects (150 cases (33.6%), 296 controls
(66.4%)) out of 474 eligible participants responded and
consented to participate in this study, resulting in an
overall response rate of 94.1% (94.9% for cases and
93.7% for controls).
The median age of the cases was 32 years (IQR 27–
39), and that for controls was 33 years (IQR 28–39). A
higher percentage of women was observed in both
groups: 81 (54%) in the case group and 188 (63.5%) in
the control group (table 1).
Bivariate analysis
Although, in bivariate analysis, male patients were 1.48
times more likely to have TB than female patients, the
association was not statistically signiﬁcant. Married
patients (crude OR (COR) 0.45; 95% CI 0.27 to 0.75)
Table 2 Sociodemographic and host-related determinants for developing tuberculosis among HIV-infected adults in
Northwest Ethiopia, 2014
Variable Cases Controls COR 95% CI p Value
Sex
Male 69 (46) 108 (36.5) 1.48 0.99 to 2.12 0.053
Female 81 (54) 188 (63.5) 1
Education
No formal education 46 (30.7) 120 (40.5) 1.04 0.51 to 2.09 0.912
Primary 48 (32) 78 (26.4) 1.67 0.82 to 3.39 0.157
Secondary 42 (28) 60 (20.2) 1.90 0.9 to 3.93 0.084
Tertiary 14 (9.3) 38 (12.8) 1
Marital status
Married 53 (35.3) 141 (47.6) 0.45 0.27 to 0.75 0.002*
Divorce/widowed 50 (33.3) 98 (33.1) 0.61 0.37 to 1.03 0.068
Never married 47 (31.3) 57 (19.3) 1
Smoking
Yes 25 (16.7) 12 (4) 4.73 2.30 to 9.72 <0.0001*
No 125 (83.3) 284 (96) 1
Khat chewing
Yes 44 (29.3) 37 (12.5) 2.9 1.77 to 4.75 <0.0001*
No 106 (70.7) 259 (87.5) 1
Alcohol
Yes 49 (32.7) 49 (16.6) 2.44 1.54 to 3.86 <0.0001*
No 101 (67.3) 247 (83.4) 1
Previous history of TB
Yes 41 (27.3) 50 (16.9) 1.85 1.15 to 2.96 0.01*
No 109 (72.7) 246 (83.1) 1
*Indicates significant difference.
Values are n (%).
COR, crude OR; TB, tuberculosis.
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were less likely to develop TB than patients who had
never been married. Cases were more likely to be
smokers (COR 4.73; 95% CI 2.3 to 9.72), khat chewers
(COR 2.9; 95% CI 1.77 to 4.75) or alcohol drinkers
(COR 2.44; 1.54 to 3.86). Study participants who had a
history of TB (COR 1.85; 95% CI 1.15 to 2.96) were
more likely to develop TB. However, educational status
was not a determinant for TB (table 2).
HAART (COR 0.33; 95% CI 0.19 to 0.56), CPT (COR
0.35; 95% CI 0.22 to 0.53) and IPT (COR 0.30; 95% CI
0.18 to 0.50) had a protective effect against TB. Subjects
with a separate kitchen in the house (COR 0.61; 95% CI
0.40 to 0.93) were less likely to develop TB. HIV-infected
adults with a TB patient in the family (COR 1.99; 95%
CI 1.11 to 3.57) were more likely to develop TB.
However, ﬂooring and a latrine in the house were not
determinants for developing TB (table 3).
Multivariable analysis
To identify independent determinants for TB, a multi-
variable logistic regression model was used. After adjust-
ment for possible confounders, some variables remained
in the multivariable model: chewing khat (adjusted OR
(AOR) 2.22; 95% CI 1.11 to 4.41), being a smoker
(AOR 5.47; 95% CI 2.26 to 13.22) and drinking alcohol
(AOR 2.49; 1.29 to 4.80) were independent determi-
nants for increased TB occurrence. However, HAART
(AOR 0.25; 95% CI 0.13 to 0.51), CPT (AOR 0.32; 95%
CI 0.19 to 0.52) and IPT (AOR 0.22; 95% CI 0.11 to
0.42) had an independent beneﬁcial protective effect
against TB. Subjects with a separate kitchen in the
house (AOR 0.48; 95% CI 0.28 to 0.83) were less likely
to develop TB. Patients who live with a TB patient in the
household (AOR 2.66; 95% CI 1.25 to 5.66) were more
likely to develop TB. Patients whose CD4 cell count was
<200 cells/µL (AOR 7.22; 95% CI 3.39 to 15.37) were
more likely to develop TB. However, sex, marital status
and a previous history of TB did not remain in the mul-
tivariable model (table 4).
DISCUSSION
This study showed that HIV-positive adults receiving
HAART, CPT and IPT were less likely to develop TB, but
smoking, alcohol consumption, khat chewing, presence
of a TB patient in the family, and CD4 count <200 cells/
µL were independent determinants for increased TB
occurrence.
Similarly to the ﬁnding of another study, this study
also showed that level of education was not a determin-
ant for TB occurrence.7 Hence, increasing the level of
Table 3 Clinical and environmental determinants for developing tuberculosis among HIV-infected adults in Northwest
Ethiopia, 2014
Variable Cases Controls COR 95% CI p Value
HAART
Yes 114 (76) 268 (90.5) 0.33 0.19 to 0.56 <0.0001*
No 36 (24) 28 (9.5) 1
CPT
Yes 83 (55.3) 231 (78) 0.35 0.22 to 0.53 <0.0001*
No 67 (44.7) 65 (22) 1
IPT
Yes 22 (14.7) 107 (36.1) 0.30 0.18 to 0.50 <0.0001*
No 128 (85.3) 189 (63.9) 1
CD4 cell count (cells/µL)
≤200 87 (58) 61 (20.6) 5.53 2.96 to 10.35 <0.0001*
200–500 46 (30.7) 169 (57.1) 1.05 0.56 to 1.97 0.86
≥500 17 (11.3) 66 (22.3) 1
TB patient in the family
Yes 25 (16.7) 27 (9.1) 1.99 1.11 to 3.57 0.021*
No 125 (83.3) 269 (90.9) 1
Separate kitchen
Yes 96 (64) 220 (74.3) 0.61 0.40 to 0.93 0.024*
No 54 (36) 76 (25.7) 1
Floor of the house
Mud/soil 123 (82) 240 (81) 1.06 0.64 to 1.76 0.814
Cement 27 (18) 56 (19) 1
Latrine
Yes 136 (90.7) 267 (90.2) 1.05 0.53 to 2.06 0.875
No 14 (9.3) 29 (9.8) 1
*Indicates significant difference.
Values are n (%).
COR, crude OR; CPT, cotrimoxazole preventive therapy; HAART, highly active antiretroviral therapy; IPT, isoniazid preventive therapy;
TB, tuberculosis.
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school training may not necessarily bring successful
behavioural change to TB prevention and control in this
source population.
Married HIV-positive adults were also less likely to
develop TB than those who were never married, consist-
ent with a previous study.8 Other studies have shown that
the prevalence of marriage is higher in higher-income
societies15 and that TB and poverty are inter-related.16
HIV-positive patients with low CD4 count were more
likely to develop TB, consistent with a previous study.7 In
addition, our ﬁndings indicating that IPT had a protect-
ive effect against TB were also consistent with a previous
research report.17 IPT reduces the mycobacterium load
and reduces the progression of latent TB to active TB.9
However, increased mycobacterial load is coupled with
progressive impairment of the mycobacterium-speciﬁc
T cell response.18
Study participants receiving HAART were less likely to
develop TB, as found previously.10 This may be due to a
strong relation between increased HAART coverage and
decreased viral load.11 Lowering of viral load was also
linked with reduced occurrence of active TB.19
We found that CPT has a protective effect against TB.
This was consistent with a previous study.13 CPT has
beneﬁcial effects in enhancing CD4 count as well as
reducing viral load.20
Cigarette smoking induces immune impairment and
damages ciliary clearance.21 22 In the present study,
smoking was an independent determinant for TB, as
found previously.23
Khat chewing is linked with immune modulation.12
No published study has detected khat chewing as an
independent determinant for TB in HIV-infected adults.
However, in this study, khat chewing was an independent
determinant for TB.
Our ﬁndings show that study subjects who consumed
alcohol were more likely to develop TB, in agreement
with previous studies.24–26 Alcohol can modulate the
immune response. Long-term alcohol consumers have
been shown to have impaired immunity.27
A past history of TB was found to be a determinant
for increased TB occurrence, but only in the bivariable
analysis. This may be explained by the low TB case
detection rate in Ethiopia.2 The established TB case
detection mechanisms may have overlooked some TB
patients. A proportion of TB patients may remain
undiagnosed—that is, they may die from other diseases
or die without visiting a healthcare centre; the detected
proportion of reoccurrence might be low. Therefore the
prevalence of reoccurrence was underestimated.
This study has the following potential limitations. As we
used a retrospective case–control approach, a temporal
Table 4 Independent determinants for tuberculosis among HIV-infected adults in Northwest Ethiopia, 2014
Variable COR (95% CI) p Value AOR (95% CI) p Value
HAART
Yes 0.33 (0.19 to 0.56) <0.0001 0.25 (0.13 to 0.51) <0.0001
No 1 1
CPT
Yes 0.35 (0.22 to 0.53) <0.0001 0.32 (0.19 to 0.55) <0.0001
No 1 1
IPT
Yes 0.30 (0.18 to 0.50) <0.0001 0.22 (0.11 to 0.41) <0.0001
No 1 1
Smoking
Yes 4.73 (2.30 to 9.72) <0.0001 5.47 (2.26 to 13.22) <0.0001
No 1 1
Khat
Yes 2.9 (1.77 to 4.75) <0.001 2.22 (1.11 to 4.41) 0.023
No 1 1
Alcohol
Yes 2.44 (1.54 to 3.86) <0.0001 2.49 (1.29 to 4.80) 0.006
No 1 1
TB patient in the family
Yes 1.99 (1.11 to 3.57) 0.021 2.66 (1.25 to 5.66) 0.011
No 1 1
Separate kitchen
Yes 0.61 (0.40 to 0.93) 0.024 0.48 (0.28 to 0.83) 0.010
No 1 1
CD4 cell count (cells/µL)
<200 5.53 (2.96 to 10.35) <0.0001 7.22 (3.39 to 15.37) <0.0001
200–500 1.05 (0.56 to 1.97) 0.86 1.31 (0.63 to 2.74) 0.461
≥500 1 1
AOR, adjusted OR; COR, crude OR; CPT, cotrimoxazole preventive therapy; HAART, highly active antiretroviral therapy; IPT, isoniazid
preventive therapy; TB, tuberculosis.
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relationship could not be established and the study
design could not prove causation. TB has the possibility
to spread to other people who are not household
members, but this study considered only family members
as close TB contacts. Information bias related to sub-
stance use (chewing khat, smoking or alcohol consump-
tion) might have also affected information accuracy.
CONCLUSION
HIV-infected adults with substance abuse (tobacco
smoking, khat chewing and alcohol) should be priori-
tised for TB screening. This study reafﬁrmed that
HAART and IPT are some of the best strategies for redu-
cing TB occurrence in HIV-infected adults. These ﬁnd-
ings provide impetus to intensify tracing of TB
household contacts.
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